# Screening for Cancer in Patients With Unprovoked VTE

> **NCT03937583** · PHASE4 · UNKNOWN · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 650 (estimated)

## Conditions studied

- Venous Thromboembolic Disease
- Respiratory Disease
- Pulmonary Disease
- Deep Venous Thrombosis
- Pulmonary Embolism
- Screening
- Undefined

## Interventions

- **DRUG:** Fludeoxyglucose 18F

## Key facts

- **NCT ID:** NCT03937583
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-23
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2021-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03937583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03937583, "Screening for Cancer in Patients With Unprovoked VTE". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03937583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*